Machine learning based on SEER database to predict distant metastasis of thyroid cancer
Lixue Qiao1, Hao Li2, Ziyang Wang3
1Thyroid Surgery Department, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Endocrine
|December 28, 2023
Summary
Machine learning models accurately predict distant thyroid cancer metastasis. The Random Forest model demonstrated superior performance, aiding early diagnosis and clinical decision-making for improved patient outcomes.
Area of Science:
- Oncology
- Medical Informatics
- Machine Learning
Background:
- Distant metastasis in thyroid cancer is a critical indicator of poor prognosis.
- Early identification of patients with distant metastasis or high risk is essential for timely intervention.
Purpose of the Study:
- To develop and evaluate machine learning models for predicting distant metastasis in thyroid cancer.
- To provide a computational tool to aid clinicians in diagnosis and treatment planning.
Main Methods:
- Utilized demographic and clinicopathological data from the NIH SEER database (2010-2015).
- Employed logistic regression to identify independent risk factors.
- Compared seven machine learning algorithms including Random Forest, Extreme Gradient Boosting, and Support Vector Machines.
- Evaluated model performance using AUC, sensitivity, accuracy, and F1 score.
Main Results:
- Identified age, gender, race, marital status, histological type, capsular invasion, and lymph node metastasis as independent risk factors.
- The Random Forest model achieved the highest performance, with an AUC of 0.960 and F1 score of 0.908 on the test set.
- The model demonstrated high sensitivity (0.929) and accuracy (0.906) in predicting distant metastasis.
Conclusions:
- Machine learning models, particularly Random Forest, show significant potential for the early diagnosis of distant thyroid cancer metastasis.
- These predictive models can assist physicians in making informed decisions for medical interventions.
- The study provides a valuable reference for clinical practice in managing thyroid cancer patients at risk of distant spread.


